Creatv MicroTech, Inc

Creatv MicroTechs mission is to dramatically reduce global cancer mortality through early detection. Our innovative blood test can detect cancer in the earliest stages, even before symptoms. It can also confirm whether a patient is responding to treatment and surveil for early signs of recurrence after treatment has finished. Clinical application of this highly sensitive and specific test will improve cancer treatment outcomes. Cancer touches all of us. Almost 40% of Americans are currently expected to receive a diagnosis of cancer in their lifetime. Over half of these diagnoses occur after significant progression, in stages 3 and 4, making it...

Early detection of cancer,companion diagnostics for immunotherapy,diagnostics to monitor treatment response,early detection of cancer recurrence,early detection of solid tumors,and cancer diagnostics

Creatv microtech, inc operates in the Biotechnology industry.

Creatv microtech, inc's revenue is 11m - 100m

Creatv microtech, inc has 11 - 50 employees.